| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/EHF2.13025 |
| P698 | PubMed publication ID | 33040495 |
| P2093 | author name string | P Christian Schulze | |
| Jasmine M F Wu | |||
| P2860 | cites work | The inflammatory protein Pentraxin 3 in cardiovascular disease | Q26738957 |
| A deficiency of ceramide biosynthesis causes cerebellar purkinje cell neurodegeneration and lipofuscin accumulation | Q27340503 | ||
| Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance | Q28291556 | ||
| A critical role for ceramide synthase 2 in liver homeostasis: I. alterations in lipid metabolic pathways | Q33796283 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism | Q34202240 | ||
| Determination of ceramides and diglycerides by the diglyceride kinase assay | Q34470701 | ||
| Absorption and lipoprotein transport of sphingomyelin | Q36298122 | ||
| Lipid mediators of insulin resistance | Q36867145 | ||
| Ceramide is a cardiotoxin in lipotoxic cardiomyopathy | Q36870574 | ||
| Involvement of sphingolipids in apoptin-induced cell killing | Q40240793 | ||
| New insights on the use of desipramine as an inhibitor for acid ceramidase | Q40244998 | ||
| Increased de novo ceramide synthesis and accumulation in failing myocardium | Q41068084 | ||
| The long-chain sphingoid base of sphingolipids is acylated at the cytosolic surface of the endoplasmic reticulum in rat liver | Q42796730 | ||
| Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle | Q43990155 | ||
| Ceramide in the antiapoptotic effect of ischemic preconditioning | Q44598220 | ||
| Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial | Q45069603 | ||
| Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure | Q46844244 | ||
| Lipotoxic very-long-chain ceramides cause mitochondrial dysfunction, oxidative stress, and cell death in cardiomyocytes | Q47615458 | ||
| Inflammation increases NT-proBNP and the NT-proBNP/BNP ratio | Q48272609 | ||
| Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials | Q48458509 | ||
| Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure | Q59192155 | ||
| Interleukin-10 and interleukin-13 inhibit proinflammatory cytokine-induced ceramide production through the activation of phosphatidylinositol 3-kinase | Q74016052 | ||
| Ceramide is upregulated and associated with mortality in patients with chronic heart failure | Q86879019 | ||
| Increased circulating IgG levels, myocardial immune cells and IgG deposits support a role for an immune response in pre- and end-stage heart failure | Q90307990 | ||
| Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI-HF trial | Q97081038 | ||
| P577 | publication date | 2020-10-11 | |
| P1433 | published in | ESC Heart Failure | Q27727376 |
| P1476 | title | Cardiovascular prognosis: a new role for ceramides and other cardiometabolites |
Search more.